David Mott
Non-Executive Director
Shire PLC American Deposit Receipt Represents 3 Shares (SHPGY)
Industry: Healthcare
Overview
Mr Mott was appointed to Shire's Board on October 31, 2007. He was also appointed to Shire's Audit, Compliance and Risk Committee on in December 2007. Mr Mott is Chief Executive Officer and President and Vice Chairman of the Board of MedImmune, Inc, roles he has held since 2000. He joined MedImmune in 1992 and held positions of increasing responsibility including the positions of Chief Financial Officer, Chief Operating Officer and President. MedImmune was acquired by AstraZeneca (AZ) in June 2007. Mr Mott is also now serving as Executive Vice President of AZ and a member of AZ's Senior Executive Team. Prior to joining MedImmune, he was a Vice President in the Health Care Investment Banking Group at Smith Barney, Harris Upham & Co., Inc. He is a member of the Board of Directors of Rib-X Pharmaceuticals and Ambit Biosciences and also serves on the Boards of Directors of the Biotechnology Industry Organization (BIO) and the Technology Council of Maryland and MdBio. He holds a bachelor's degree in economics and government from Dartmouth College, New Hampshire, USA.
Did anyone at Microsoft ever watch the (gasp!) offensively funny show Family Guy?
Ex-Morgan Stanley exec Zoe Cruz is now heading her own hedge fund. Are Wall Street's leaders done?
Martha, Bernie and Skilling know that what you wear for court can go a long way in public perception.
Health Care
